BEIGENE: OVERSEAS REGULATORY ANNOUNCEMENT - FORM 8-K
BEIGENE: LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
BEIGENE: APPOINTMENT OF MEMBER OF COMMERCIAL AND MEDICAL AFFAIRS ADVISORY COMMITTEE
BEIGENE: INSIDE INFORMATION - BEIGENE RECEIVES FDA APPROVAL FOR TEVIMBRA (TISLELIZUMAB) FOR THE TREATMENT OF ADVANCED OR METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA AFTER PRIOR CHEMOTHERAPY
BEIGENE: Next Day Disclosure Return
BEIGENE: OVERSEAS REGULATORY ANNOUNCEMENT - FORM 8-K
BEIGENE: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
BEIGENE: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
BEIGENE: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
BEIGENE: Next Day Disclosure Return
BEIGENE: Next Day Disclosure Return
BEIGENE: Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
BEIGENE: Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
BEIGENE: Next Day Disclosure Return
BEIGENE: OVERSEAS REGULATORY ANNOUNCEMENT - FORM 10-K
BEIGENE: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
BEIGENE: VOLUNTARY ANNOUNCEMENT - UPDATE REGARDING RECENT BUSINESS DEVELOPMENTS
BEIGENE: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
BEIGENE: Next Day Disclosure Return
BEIGENE: Next Day Disclosure Return
No Data